Core Viewpoint - The article discusses the recent private placement by Cambricon, highlighting the issuance price, the amount raised, and the key investors involved, particularly emphasizing the significant role of GF Fund in this transaction [2][6][8]. Summary by Sections Issuance Details - Cambricon announced a private placement with an issuance price of 1195.02 yuan per share, totaling 3.3349 million shares and raising approximately 3.985 billion yuan [2][7]. - The issuance price represents a 110.51% ratio compared to the issuance floor price [6][7]. - The issuance was conducted through a competitive bidding process, with the pricing benchmark set for September 18, 2025 [7]. Key Investors - GF Fund emerged as the largest beneficiary, acquiring 1,010,861 shares for a total of approximately 1.208 billion yuan [8][9]. - Other notable investors include UBS AG and Xinhua Asset Management, with respective allocations of 364,010 shares and 351,458 shares [9]. Fund Utilization - The funds raised will be allocated to projects aimed at enhancing Cambricon's competitiveness in the large model field, including chip and software platform projects, as well as supplementing working capital [10][11]. - The total investment for the chip platform project is estimated at 290 million yuan, with 205.43 million yuan sourced from the raised funds [12]. Financial Performance - As of the second quarter of 2025, Cambricon reported total assets of 8.42 billion yuan and net assets of 6.76 billion yuan, with a significant revenue increase of 4347.82% year-on-year, amounting to 2.88 billion yuan [13][14]. - The net profit attributable to shareholders reached approximately 1.04 billion yuan, a substantial recovery from a loss of 530 million yuan in the same period the previous year [13][15].

Group 1 - The company announced a private placement of 3.3349 million shares at a price of 1195.02 yuan per share [1] - The total amount of funds raised from this issuance is 3.985 billion yuan, with a net amount of 3.953 billion yuan [1] - The issuance involves 13 specific investors, with UBS AG receiving an allocation of 4.35 billion yuan, Guangfa Fund Management Co., Ltd. receiving 1.208 billion yuan, and Nord Fund Management Co., Ltd. receiving 279 million yuan [1]

| 序 | 发行对象名称 | 获配股数 | 获配金额 | 限售期 | | --- | --- | --- | --- | --- | | 름 | | (股) | (元) | (月) | | 1 | 广发基金管理有限公司 | 1.010.861 | 1,207.999.112.22 | 6 | | 2 | UBS AG | 364,010 | 434,999,230.20 | 6 | | 3 | 新华资产管理股份有限公司 | 351,458 | 419,999,339.16 | 6 | | 4 | 汇添富基金管理股份有限公司 | 296,647 | 354,499,097.94 | 6 | | 5 | 诺德基金管理有限公司 | 233,217 | 278,698,979.34 | 6 | | 6 | 国泰海通证券股份有限公司 | 221,753 | 264,999,270.06 | 6 | | 7 | 国信证券(香港)资产管理有限公司 | 184,097 | 219,999,596.94 | 6 | | 8 | 博时基金管理有限公司 | 132,215 | 157,999,569.30 | 6 | | 9 | ...

中国经济网北京9月30日讯今日，广发基金公告，广发聚富混合增聘陈宇庭。 陈宇庭2016年1月至2018年2月在海富通基金管理有限公司先后任量化研究员、投资经理助理。2018年3 月1日加入广发基金管理有限公司，曾任量化投资部研究员、基金经理助理。 广发聚富混合成立于2003年12月3日，截至2025年9月29日，其今年来收益率为3.55%，成立来收益率为 822.48%，累计净值为4.3299元。 | 基金名称 | 广发聚富开放式证券投资基金 | | --- | --- | | 基金同样 | 广发聚富混合 | | 基金主代码 | 270001 | | 基金前端交易代码 | 270001 | | 基金后端交易代码 | 270011 | | 基金管理人名称 | 广发基金管理有限公司 | | 公告依据 | 《公开募集证券投资基金信息按摩管理办法》、《盐金管理公 司投资管理人员管理指导意见》、《广发来富开放式证券投 资基金基金合同》 | | 基金经理事更发展 | 增聘基金经理 | | 新任基金经理姓名 | 陈宇脏 | | 共同管理本基金的其他基金经理姓名 | 林奕祥 | ...

Group 1 - The core viewpoint of the news is that Runxin Technology's stock has seen a significant increase of 5.93%, reaching a price of 23.74 CNY per share, with a trading volume of 975 million CNY and a turnover rate of 8.39%, resulting in a total market capitalization of 12.169 billion CNY [1] - Runxin Technology, established on October 9, 2000, and listed on December 10, 2015, is based in Shanghai and primarily engages in providing IC application solutions and technical support services, which contribute to its IC product sales [1] - The revenue composition of Runxin Technology includes: digital communication chips and system-level application products (29.11%), discrete devices (20.47%), audio and power amplifiers (19.88%), RF and power amplifiers (16.13%), and IoT communication modules (14.42%) [1] Group 2 - From the perspective of the top circulating shareholders, GF Fund's Guangfa CSI 1000 ETF (560010) has entered the top ten circulating shareholders of Runxin Technology, holding 1.8 million shares, which accounts for 0.36% of the circulating shares, with an estimated floating profit of approximately 2.394 million CNY [2] - Guangfa CSI 1000 ETF was established on July 28, 2022, with a latest scale of 30.718 billion CNY, and has achieved a year-to-date return of 27.14%, ranking 2109 out of 4220 in its category, and a one-year return of 47.36%, ranking 1426 out of 3846 [2]

Group 1 - The core viewpoint of the news is that CaiXun Technology Co., Ltd. has seen a significant stock price increase of 5.05%, reaching 27.44 CNY per share, with a total market capitalization of 12.381 billion CNY [1] - CaiXun's main business involves providing industrial internet technology and services, with revenue composition as follows: 61.25% from technical services, 17.77% from software product development and sales, 16.86% from system integration, and 3.56% from other supplementary services [1] - The company is located in Nanshan District, Shenzhen, Guangdong Province, and was established on January 6, 2004, with its listing date on March 23, 2018 [1] Group 2 - From the perspective of fund holdings, Guangfa Fund has a significant position in CaiXun, with its Guangfa Reform Mixed Fund (001468) holding 128,700 shares, accounting for 1.77% of the fund's net value, ranking as the tenth largest holding [2] - The Guangfa Reform Mixed Fund has achieved a year-to-date return of 29.81% and a one-year return of 33.53%, with a total fund size of 197 million CNY [2] - The fund manager, Chen Shaoping, has a tenure of 18 years and 309 days, with the best fund return during his management being 74.29% [3]

Company Overview - Shuyou Shen (Beijing) Biopharmaceutical Co., Ltd. is located in Beijing Economic and Technological Development Zone, established on August 16, 2002, and listed on April 15, 2011. The company primarily engages in the research, production, and sales of biological products and some chemical drugs [1]. Financial Performance - As of September 29, Shuyou Shen's stock price fell by 0.65% to 33.65 CNY per share, with a trading volume of 479 million CNY and a turnover rate of 3.16%. The total market capitalization is 16.077 billion CNY. The stock has experienced a cumulative decline of 6.81% over the past three days [1]. - The main revenue sources for Shuyou Shen are: 59.17% from injectable mouse nerve growth factor (Sutai Shen), 33.19% from compound polyethylene glycol electrolyte powder, and 7.63% from other products [1]. Fund Holdings - According to data from the top ten heavy stocks of funds, one fund under GF Fund holds Shuyou Shen as a significant position. The GF Hong Kong-Shenzhen Medical Mixed A Fund (014114) held 235,700 shares in the second quarter, accounting for 2.86% of the fund's net value, ranking as the tenth largest holding. The estimated floating loss today is approximately 51,900 CNY, with a total floating loss of 579,800 CNY during the three-day decline [2]. - The GF Hong Kong-Shenzhen Medical Mixed A Fund was established on December 29, 2021, with a current scale of 204 million CNY. Year-to-date returns are 76.81%, ranking 223 out of 8,244 in its category; the one-year return is 84.5%, ranking 709 out of 8,080; and since inception, the return is 14.5% [2]. Fund Management - The fund manager of GF Hong Kong-Shenzhen Medical Mixed A Fund is Wu Xingwu, who has been in the position for 10 years and 233 days. The total asset size of the fund is 9.853 billion CNY, with the best fund return during his tenure being 112.41% and the worst being -33.74% [3].

Group 1 - DataPort's stock price has declined for three consecutive days, with a total drop of 7.43% during this period, currently trading at 37.35 CNY per share [1] - The company, Shanghai DataPort Co., Ltd., primarily engages in data center server hosting services and network bandwidth services, with 99.31% of its revenue coming from IDC services [1] - The total market capitalization of DataPort is 26.831 billion CNY, with a trading volume of 2.516 billion CNY and a turnover rate of 9.34% [1] Group 2 - According to data, GF Fund's Guangfa CSI 1000 ETF (560010) is among the top ten circulating shareholders of DataPort, having increased its holdings by 660,800 shares in the second quarter [2] - The ETF currently holds 1.8888 million shares, representing 0.26% of the circulating shares, with an estimated floating loss of approximately 1.6055 million CNY today and a total floating loss of 5.6665 million CNY over the three-day decline [2] - Guangfa CSI 1000 ETF has a total scale of 30.718 billion CNY, with a year-to-date return of 25.44% and a one-year return of 53.3% [2] Group 3 - The fund manager of Guangfa CSI 1000 ETF is Luo Guoqing, who has been in the position for 9 years and 355 days, managing assets totaling 67.565 billion CNY [3] - During his tenure, the best fund return achieved was 80.65%, while the worst return was -48.08% [3]

Group 1 - The Hong Kong Innovative Drug ETF (513120) experienced a decline of 1.60% on September 26, with a trading volume of 6.703 billion yuan [1] - The fund's shares decreased by 25 million, bringing the total shares to 16.407 billion, while the shares increased by 2.655 billion over the past 20 trading days [1] - The latest net asset value of the fund is calculated at 24 billion yuan [1] Group 2 - The performance benchmark for the Hong Kong Innovative Drug ETF is the return rate of the China Securities Hong Kong Innovative Drug Index (in RMB) [1] - The fund is managed by Guangfa Fund Management Co., Ltd., with Liu Jie as the fund manager [1] - Since its establishment on July 1, 2022, the fund has achieved a return of 46.29%, while the return over the past month is -2.76% [1]

1. Report Industry Investment Rating No relevant content provided. 2. Core Viewpoints of the Report The report focuses on the performance of the ETF fund market, summarizing the performance and fund flows of the ETF fund market, different popular sub - type ETF funds, and innovative theme and sub - industry ETF funds in the past week (September 22 - September 26) for investors' reference [1]. 3. Summary by Relevant Catalogs 3.1 ETF Market Overall Performance - Market performance: Most stock ETFs rose this week. A - share TMT ETFs and Shanghai - Hong Kong - Shenzhen theme ETFs had the largest increases, with an average increase of 4.39% and 4.28% respectively for funds above a certain scale. Conversely, A - share consumer ETFs and Hong Kong stock dividend ETFs had significant declines, with an average decline of 2.24% and 2.15% respectively for funds above a certain scale [2][5]. - Fund flow: Funds flowed significantly into A - share TMT ETFs, with a net inflow of 17.889 billion yuan throughout the week. In contrast, A - share small - and - medium - cap ETFs and A - share cyclical ETFs experienced fund outflows, with net outflows of 2.251 billion yuan and 2.023 billion yuan respectively throughout the week [3][9]. - Lists of funds: The report also lists the top - performing funds in terms of recent weekly returns, weekly fund inflows, and weekly fund outflows [11][12][13]. 3.2 Different Popular Sub - type ETF Funds Market Performance The report presents the market performance of various sub - type ETFs, including A - share ETFs (broad - based index, industry, SmartBeta, theme), Hong Kong stock ETFs (broad - based index, industry, SmartBeta, theme), Shanghai - Hong Kong - Shenzhen ETFs (industry, theme), US stock ETFs (broad - based index, industry), other QDII - ETFs, bond ETFs, and commodity ETFs, showing their latest scale, weekly fund flow, weekly return, weekly trading volume, recent one - month return, and year - to - date return [15][30][37]. 3.3 Innovative Theme and Sub - industry ETF Funds Market Performance The report shows the market performance of highly - concerned innovative theme and sub - industry ETF funds, including TMT innovation themes, consumption sub - industries, pharmaceutical sub - industries, new energy themes, central and state - owned enterprise themes, stable - growth themes, Shanghai - Hong Kong - Shenzhen/Hong Kong Stock Connect sub - industries, dividend/dividend low - volatility index families, and ChiNext index families, presenting their index abbreviations, weekly returns, year - to - date returns, fund codes, representative fund abbreviations, weekly returns, and latest scale [46][47][48].